Hochschulschrift
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
70 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Universität zu Köln, Dissertation, 2020
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2021?]
Ähnliche Objekte (12)
FGFR1 is a potential therapeutic target in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
Evaluation of galectin-1 as a target for therapy in neuroblastoma
Evaluation of Galectin-1 as a Target for Therapy in Neuroblastoma
The MYCN oncogene as a minimal residual disease marker and therapeutic target in neuroblastoma
Progressive neuroblastoma : innovation and novel therapeutic strategies
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target
Immune-oncology targets and therapeutic response of cell pyroptosis-related genes with prognostic implications in neuroblastoma
Developing preclinical models of neuroblastoma: driving therapeutic testing
FGFR1 is a potential therapeutic target in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
Evaluation of galectin-1 as a target for therapy in neuroblastoma
Evaluation of Galectin-1 as a Target for Therapy in Neuroblastoma
The MYCN oncogene as a minimal residual disease marker and therapeutic target in neuroblastoma
Progressive neuroblastoma : innovation and novel therapeutic strategies
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target
Immune-oncology targets and therapeutic response of cell pyroptosis-related genes with prognostic implications in neuroblastoma
Developing preclinical models of neuroblastoma: driving therapeutic testing
FGFR1 is a potential therapeutic target in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
Evaluation of galectin-1 as a target for therapy in neuroblastoma
Evaluation of Galectin-1 as a Target for Therapy in Neuroblastoma
The MYCN oncogene as a minimal residual disease marker and therapeutic target in neuroblastoma
Progressive neuroblastoma : innovation and novel therapeutic strategies
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target
Immune-oncology targets and therapeutic response of cell pyroptosis-related genes with prognostic implications in neuroblastoma